The method can be applied to investigate the biological mechanisms of how SGLT2 inhibition affects type 2 diabetes mellitus (T2DM) and prostate cancer (Bouras et al., 2022; Lin et al., 2022). The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.